REGENXBIO Inc.RGNXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank25
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-123.96M
↓ 86% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-66.78M
Historical baseline
PeriodValueYoY Change
TTM$-123.96M+28.4%
2024$-173.13M+20.7%
2023$-218.41M-5.3%
2022$-207.49M-194.8%
2021$218.88M+504.9%
2020$-54.06M+49.8%
2019$-107.70M-202.9%
2018$104.65M+280.5%
2017$-57.99M-19.4%
2016$-48.56M-